Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Total Non-Current Liabilities data on file, last reported at $62.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 41.15% year-over-year to $62.9 million; the trailing twelve-month figure through Mar 2026 stood at $62.9 million (up 41.15% YoY), and the FY2025 full-year result was $59.6 million, up 18.22% from the prior year.
• Total Non-Current Liabilities advanced to $62.9 million in Q1 2026, from $59.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $62.9 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• A 5-year average of $30.5 million and a median of $33.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities surged 713.47% in 2023 and dropped 16.57% in 2025, its largest moves.
• Tracing CATX's Total Non-Current Liabilities over 5 years: stood at $2.8 million in 2022, then surged by 713.47% to $22.7 million in 2023, then jumped by 121.81% to $50.4 million in 2024, then grew by 18.22% to $59.6 million in 2025, then advanced by 5.61% to $62.9 million in 2026.
• Business Quant data shows CATX's Total Non-Current Liabilities at $62.9 million in Q1 2026, $59.6 million in Q4 2025, and $52.3 million in Q3 2025.